At the height of the pandemic in February of 2021, Prime Minister Justin Trudeau announced he had found a partner to make millions of doses…
Comments closedStill COVIDing Canada Posts
BC Conservative Leader John Rustad Suggests Province Would Participate in ‘Nuremberg’-Style COVID-19 Trials
BC Conservative leader John Rustad assured anti-vaccine activists British Columbia would be open to joining other jurisdictions in legal proceedings inspired by the Nuremberg Trials that would be aimed at prosecuting those deemed responsible for COVID-19 public health measures and vaccines.
“Nuremberg 2.0,” an idea popular among COVID-19 conspiracy theorists and the online far-right, is simultaneously inspired by the Nuremberg Code, a set of ethical principles on human experimentation, as well as the Nuremberg Trials that prosecuted Nazi leaders after the Second World War.
Nuremberg 2.0 advocates typically call for those who created, justified or enforced public health measures — including politicians, doctors, academics, journalists and police — to be jailed and even executed for “crimes against humanity.”
Comments closedUpdated COVID, flu vaccines arrive in London region, and health officials suggest you get both
Shipments of updated COVID-19 and flu vaccines have arrived in the London region, according to the Middlesex-London Health Unit (MLHU), with more rolling in as respiratory virus season inches closer.
A spokesperson for the MLHU said high risk populations are eligible for the shots for now, and the general population will have to wait until the end of the month to update their immunization.
Comments closedCall for the creation of a national registry for long COVID
The second Canadian Symposium on Long COVID came to a close in Edmonton on Friday, with an urgent call for the establishment of a national registry for the condition.
The event, organized by Long Covid Web, a network dedicated to research and support for people suffering from post COVID-19 condition, in collaboration with the University of Alberta, University of Calgary, and Alberta Health Services, brought together researchers, clinicians and patients to discuss the challenges associated with the condition.
The speakers’ testimonies highlighted the devastating impact of long COVID on patients’ daily lives.
Comments closedOttawa’s wastewater surveillance program extended for another year
Two months after the Ontario government pulled the plug on wastewater surveillance, Ottawa health and research institutions have teamed up to extend the program in the city for a least another year.
Calling it an innovative solution that allowed for better monitoring of COVID-19 in the community, CHEO, the CHEO Research Institute, the University of Ottawa and Ottawa Public Health announced an extension of wastewater surveillance on Friday.
In addition to monitoring COVID-19 levels in wastewater, the program monitors levels of influenza, RSV and mpox in Ottawa. The program has been extended until September 2025.
Comments closeduOttawa, CHEO and OPH extend monitoring of viruses in wastewater to 2025
Comments closedOur research group is truly grateful for the overwhelming support we’ve received from the community over the past few months through emails, letters, and phone calls advocating for the continuation of our wastewater monitoring system.
We’ve gained invaluable insights into how this information is essential for community members facing health challenges, and we are thrilled to continue providing this vital service. A heartfelt thank you to OPH, CHEO, and CHEO-RI for their unwavering support.
No flu or COVID-19 vaccines for medical clinics as Alberta’s fall immunization launch nears
Family doctors and nurse practitioners have been told they will not be receiving deliveries of flu or COVID-19 vaccines in time for the fall immunization program launch later this month. And it is unclear if they will get any at all.
In addition to AHS public health clinics and pharmacies, community medical clinics can administer publicly funded vaccines, including those that protect against COVID and influenza.
But shipments of vaccines — to these clinics — have stopped, jeopardizing their participation in the fall immunization campaign.
Comments closedCOVID-19 boosters start rolling out to some Canadians. Who can get them?
Updated COVID-19 vaccines are starting to roll out to some high-risk Canadians, but others will have to wait a little while longer before these new shots are offered to them.
Last month, Health Canada approved Pfizer and Moderna’s latest COVID-19 vaccines targeting the most recent variants of the virus.
Both shots are approved for everyone aged six months and older.
The new mRNA vaccines from both pharmaceutical companies target the KP.2 subvariant of Omicron that was dominating COVID-19 spread earlier this year.
Comments closedCOVID-19 prevalence high and rising across most of province as BCCDC revamps reporting dashboards
The prevalence of SARS-CoV-2 – the virus that causes COVID-19 – in B.C. wastewater is high and rising across most regions, according to the latest data from the B.C. Centre for Disease Control.
The BCCDC released its first weekly data update of the 2024-25 respiratory illness season Thursday, and took the opportunity to dramatically revise the information it presents and the way it is presented.
Gone is the previous year’s “COVID-19 Situation Report” dashboard, replaced with a new dashboard titled “Viral Respiratory Outcomes.”
While the situation report included specific numbers for newly confirmed infections, hospital admissions, critical care admissions and deaths within 30 days of a positive COVID test, the new dashboard reports the latter three numbers as a rate per million residents.
Comments closedFor Canadians seeking a non-mRNA COVID vaccine, lack of Novavax shot is ‘unfair,’ advocates say
The federal government’s decision to not provide Novavax’s COVID-19 vaccine this respiratory virus season raises health equity concerns, experts and advocates say, as some Canadians look to the U.S. to get the shot.
The Public Health Agency of Canada said it won’t provide the protein-based vaccine called Nuvaxovid because the manufacturer required a minimum order that far exceeds last year’s uptake of the vaccine.
The health agency said 125,000 Nuvaxovid doses were ordered in 2023, but only 5,529 were administered. This fall, it will only supply provinces and territories with the reformulated Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines.
But some Canadians who say they are immunocompromised and have had adverse reactions to the mRNA vaccines are calling the decision unfair.
Comments closedCanadian government not ordering Novavax’s protein-based COVID-19 vaccine this year
TORONTO – The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing low demand.
It says the manufacturer requires a minimum order of its updated protein-based vaccine, called Nuvaxovid, which far exceeds the uptake by Canadians last year.
The agency says a very small portion of the doses ordered in 2023 were used and that its decision reflects efforts to limit vaccine wastage.
It is distributing two mRNA vaccines — made by Pfizer-BioNTech and Moderna — that are approved for adults and children six months and older.
Comments closedThe N.W.T. now has a virus ‘dashboard’ so you can see COVID-19, flu and RSV trends
Data collected by wastewater monitoring in six N.W.T. communities is being put to a new use: an online dashboard that tracks how much COVID-19, flu and RSV are in those communities.
The N.W.T. government announced the new dashboard Wednesday in a news release. It covers Yellowknife, Behchokǫ̀, Fort Smith, Fort Simpson, Hay River and Norman Wells.
The dashboard is updated once a week on Tuesdays. For the most recent reporting period, as of Wednesday, it didn’t have data for Hay River but showed COVID-19 was still being detected to a high or moderate level in all the other communities. No detection was noted for flu or RSV.
Comments closedWant To Prevent Long Covid? Should You Take Metformin Or Paxlovid?
Previously, I wrote about Paxlovid being underprescribed for treating acute Covid in patients at high risk for serious illness. The FDA granted an Emergency Use Authorization based on data showing that “Paxlovid significantly reduced the proportion of people with Covid-19 related hospitalization or death” by 88% compared to placebo.
In unvaccinated people, Paxlovid was also associated with a 26% lower risk of long Covid in a study by Ziyad Al-Aly.
The data on Paxlovid for those previously vaccinated is mixed. A smaller study from the University of California at San Francisco found no benefit in people who had been previously vaccinated.
Comments closedHealth Canada approves Pfizer-BioNTech’s updated COVID-19 vaccine
Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants of the virus.
Pfizer-BioNTech’s mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version that targeted the XBB.1.5 Omicron subvariant.
The approval of Comirnaty follows last week’s authorization of Moderna’s updated Spikevax mRNA vaccine and Novavax’s updated protein-based vaccine, Nuvaxovid.
Comments closed